Cargando…

Silexan for treatment of anxiety and depression in the context of COVID-19

Detalles Bibliográficos
Autores principales:	Bartova, Lucie, Dold, Markus, Fugger, Gernot, Weidenauer, Ana, Rujescu, Dan, Kasper, Siegfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and ECNP. 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946880/ https://www.ncbi.nlm.nih.gov/pubmed/36867894 http://dx.doi.org/10.1016/j.euroneuro.2023.02.015

Ejemplares similares

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series
por: Bartova, L., et al.
Publicado: (2023)

Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
por: Bartova, Lucie, et al.
Publicado: (2022)

Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
por: Dold, Markus, et al.
Publicado: (2023)

Age as a moderating factor of treatment resistance in depression
por: Kautzky, Alexander, et al.
Publicado: (2023)

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
por: Bartova, Lucie, et al.
Publicado: (2021)

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment
por: Dold, Markus, et al.
Publicado: (2020)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials
por: Möller, Hans-Jürgen, et al.
Publicado: (2017)

Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
por: Bartova, Lucie, et al.
Publicado: (2021)

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
por: Fugger, Gernot, et al.
Publicado: (2020)

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
por: Dold, Markus, et al.
Publicado: (2018)

Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta‐analysis
por: von Känel, Roland, et al.
Publicado: (2021)

Case report: Interstitial pneumonitis after initiation of lamotrigine
por: Watzal, Victoria, et al.
Publicado: (2023)

No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial
por: Seifritz, Erich, et al.
Publicado: (2020)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
por: Bartova, L., et al.
Publicado: (2022)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
por: Bartova, Lucie, et al.
Publicado: (2016)

Combining machine learning algorithms for prediction of antidepressant treatment response
por: Kautzky, Alexander, et al.
Publicado: (2020)

Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging
por: Baldinger, Pia, et al.
Publicado: (2015)

Making Sense of: Sensitization in Schizophrenia
por: Weidenauer, Ana, et al.
Publicado: (2016)

Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine
por: Preiss, Maximilian, et al.
Publicado: (2023)

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
por: Kautzky, A., et al.
Publicado: (2018)

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

Depression and anxiety during COVID-19
por: Daly, Michael, et al.
Publicado: (2022)

Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis
por: Yap, Wuan Shuen, et al.
Publicado: (2019)

Depression and anxiety during COVID-19 – Authors' reply
por: Santomauro, Damian F, et al.
Publicado: (2022)

Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19
por: Wei, Ning, et al.
Publicado: (2020)

Mechanische Schutzfixierung – Herausforderungen und Management: Fallvignetten aus der psychiatrischen Intermediate Care Station der Wiener Universitätsklinik
por: Popper, Valentin, et al.
Publicado: (2021)

Anxiety, depression and sleep problems: a second wave of COVID-19
por: Peretti-Watel, Patrick, et al.
Publicado: (2020)

Anxiety, depression, and posttraumatic stress in nurses during the COVID-19 outbreak
por: Di Tella, Marialaura, et al.
Publicado: (2021)

No Interacting Influence of Lavender Oil Preparation Silexan on Oral Contraception Using an Ethinyl Estradiol/Levonorgestrel Combination
por: Heger-Mahn, Doris, et al.
Publicado: (2014)

Anxiety and depression among Chinese adolescents during the COVID-19: an overestimation of the problem
por: Kojok, Lara, et al.
Publicado: (2021)

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives
por: Fabbri, Chiara, et al.
Publicado: (2018)

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
por: Dold, Markus, et al.
Publicado: (2015)

Coping behaviors associated with decreased anxiety and depressive symptoms during the COVID-19 pandemic and lockdown
por: Fullana, Miquel A., et al.
Publicado: (2020)

Responses to the comment: Anxiety and depression among Chinese adolescents during the COVID-19: an overestimation of the problem
por: Liu, Rui, et al.
Publicado: (2022)

Anxiety and depression during the first wave of COVID-19 in Germany – results of repeated cross-sectional surveys
por: Bräscher, A.-K., et al.
Publicado: (2021)

Response to: Does COVID-19 pose a challenge to the diagnoses of anxiety and depression? A psychologist's view
por: House, Allan
Publicado: (2022)

Depressive and anxiety symptoms in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2021)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

The COVID-19 syndemic is not global: context matters
por: Mendenhall, Emily
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b6qqi9r8t7ciui85mmehu40pig